Clinical trial · Observational
Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer
Correlation of SNP Patterns With Fine Needle Aspiration Cytomorphology in High Risk Postmenopausal Women
NCT00329017CI-TRIAL-00041091withdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): No patients enrolled
Summary
Brief summary (as posted)
A study to examine the potential associations between common single nucleotide polymorphisms and pre-cancerous conditions in breast tissue specimens from postmenopausal women.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fine needle aspiration | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Post-menopausal women who are at increased risk for development of breast cancer on the basis of family or personal history.
- interventionNames
- Procedure: Fine needle aspiration
Primary outcomes (1)
- measure
- Correlation of SNP patterns with cytlomorphology of breast fine needle aspirates.
- timeFrame
- ongoing
- description
- develoment of algorithm for prediction of risk of developing breast cancer.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * postmenopausal women on or off hormone replacement therapy * at high risk of developing breast cancer determined by family or personal history * postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration * willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies Exclusion Criteria: * women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.
References
Publications (0)
Data not yet available
No reference posted for this study.